Teriparatide

Teriparatide is a synthetic version of parathyroid hormone that is used to treat osteoporosis in adults. It helps to increase bone density and reduce the risk of fractures by stimulating the production of new bone by the body's osteoblasts. Teriparatide is typically injected daily for up to two years, and is generally reserved for those who have not responded to other treatments for osteoporosis. Common side effects include nausea, headache, and injection site reactions.

Teriparatide is a medication used to treat osteoporosis, a condition that weakens bones and makes them more likely to break. It is a man-made form of parathyroid hormone (PTH), a hormone that helps the body build new bone. Teriparatide is sold under the brand name Forteo. 

Teriparatide is given as an injection under the skin (subcutaneous) once a day. It is typically used for up to 2 years. The most common side effects of teriparatide include leg cramps, nausea, dizziness, and headache. Teriparatide is not for everyone. It is not recommended for people with certain medical conditions, such as Paget's disease of bone or a history of skeletal malignancies. Women who are pregnant or breastfeeding should not take teriparatide.

Anatomical Therapeutic Chemical Classification
H - Systemic hormonal preparations, excluding sex hormones and insulins
H05 Calcium homeostasis
H05A - Parathyroid hormones and analogues
H05AA Parathyroid hormones and analogues
External Links